Blog
Elevidys: A Breakthrough Gene Therapy for Duchenne Muscular Dystrophy
Byezypill
January 2, 2025
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting young boys. The absence of functional dystrophin,
Kisunla: A Breakthrough in the Treatment of Early Symptomatic Alzheimer’s Disease
Kisunla (donanemab) is a monoclonal antibody developed by Eli Lilly and Company for the treatment of early symptomatic Alzheimer’s disease. Approved by the U.S. Food
Byezypill
January 18, 2025
“Revolutionizing Healthcare: The Role of Remote Patient Monitoring and Telemedicine in Modern Medicine”
“Revolutionizing Healthcare: The Role of Remote Patient Monitoring and Telemedicine in Modern Medicine” Remote Patient Monitoring (RPM) and telemedicine have revolutionized healthcare by enabling continuous
Byezypill
January 2, 2025
Advancements in Gene Editing Propel Personalized Medicine
Gene editing technologies, particularly CRISPR-Cas9, have significantly advanced personalized medicine by enabling precise modifications to an individual’s genetic code. This precision allows for treatments tailored
Byezypill
January 2, 2025
Antimicrobial-Resistant Infections: A Growing Threat in North America
Antimicrobial resistance (AMR) poses a significant global health threat, primarily stemming from its misuse and overuse in both veterinary and public healthcare systems. The consequences
Byezypill
December 26, 2024